Supplemental material
Hematology
Volume 28, 2023 - Issue 1
Open access
1,347
Views
2
CrossRef citations to date
0
Altmetric
Research Article
MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan
Chiho Furuyaa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Yoshinori Hashimotob Department of Hematology, Tottori Prefectural Central Hospital, Tottori City, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-3374-9814View further author information
, Soji Morishitac Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0003-1081-0130View further author information
, Tadaaki Inanoa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-9618-6588View further author information
, Tomonori Ochiaia Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0001-6156-4211View further author information
, Shuichi Shiranea Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
, Yoko Edahiroa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-8386-1871View further author information
, Marito Arakic Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japanhttps://orcid.org/0000-0002-3502-5000View further author information
, Miki Andoa Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, JapanView further author information
& Norio Komatsua Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;c Department of Advanced Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan;d Laboratory for the Development of Therapies against MPN, Juntendo University Graduate School of Medicine, Tokyo, Japan;e PharmaEssentia Japan KK, Tokyo, JapanCorrespondence[email protected]
https://orcid.org/0000-0003-1880-9126View further author information
show allhttps://orcid.org/0000-0003-1880-9126View further author information
Article: 2229131
|
Received 22 Feb 2023, Accepted 16 Jun 2023, Published online: 28 Jun 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.